MILDRONATE POTENTIAL IN PATIENTS WITH CARDIOVASCULAR DISEASE

MILDRONATE POTENTIAL IN PATIENTS WITH CARDIOVASCULAR DISEASE

.

Bibliographic Details
Main Authors:	V. P. Mikhin, F. E. Khlebodarov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2010-08-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1473

Similar Items

Mildronate in cardiology practice – current evidence, ongoing research, and future perspectives
by: V. P. Mikhin, et al.
Published: (2012-02-01)

Mildronate effectiveness in post-hospital rehabilitation of patients with myocardial infarction
by: V. P. Mikhin, et al.
Published: (2012-04-01)

MILDRONATE POTENTIAL FOR CARDIAC ARRHYTHMIA PREVENTION IN PERIOPERATIVE PERIODcardiac arrhythmias, ischemia, metabolic disturbances, cytoprotectors, antioxidants, operation-related stress, general anesthesia, Mildronate
by: V. P. Mikhin, et al.
Published: (2014-02-01)

Experience with mildronate in cerebrovascular diseases
by: N. V. Pizova
Published: (2015-12-01)

"TREAT THE PATIENT, RATHER THAN THE DISEASE": MILDRONATE AS A COMPONENT OF COMPLEX CARDIOVASCULAR THERAPY
by: I. G. Gordeev, et al.
Published: (2013-06-01)

MILDRONATE POTENTIAL FOR CORRECTING COGNITIVE DYSFUNCTION IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
by: M. E. Statsenko, et al.
Published: (2011-08-01)

ANTIOXIDANT EFFECT OF MILDRONATE IN PATIENTS AFTER CORONARY REVASCULARISATION
by: I. G. Gordeev, et al.
Published: (2009-02-01)

Mildronate effects on cognitive function in elderly patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2012-10-01)

ENDOTHELIAL DYSFUNCTION AND ITS CORRECTION WIT CYTOPROTECTORS IN PATIENTS WITH STABLE EFFORT ANGINA AND ARTERIAL HYPERTENSION
by: F. E. Khlebodarov, et al.
Published: (2009-12-01)

Mildronate efficacy and tolerance in chronic heart failure patients therapy
by: A. S. Galiavich, et al.
Published: (2005-10-01)

INFLUENCE OF MILDRONATE ON EFFICIENCY OF ANTIANGINAL THERAPY IN PATIENTS WITH STABLE BURDEN ANGINA
by: N. P. Kutishenko, et al.
Published: (2015-12-01)

INFLUENCE OF MILDRONATE ON EFFICIENCY OF ANTIANGINAL THERAPY IN PATIENTS WITH STABLE BURDEN ANGINA
by: N. P. Kutishenko, et al.
Published: (2015-12-01)

Central hemodynamics changes in patients with coronary heart disease, stable effort angina, treated with mildronate
by: M. V. Baluda, et al.
Published: (2007-08-01)

COMPARATIVE EFFECTIVENESS OF CARDIOCYTE PROTECTORS IN COMPLEX MANAGEMENT OF ARTERIAL HYPERTENSION
by: F. E. Khlebodarov, et al.
Published: (2009-08-01)

CLINICAL EFFECTIVENESS AND ANTIOXIDANT ACTIVITY OF MILDRONATE IN ISCHEMIC STROKE
by: M. Yu. Maksimova, et al.
Published: (2009-08-01)

EXERCISE CAPACITY IN PATIENTS WITH CORONARY HEART DISEASE AND PERIPHERAL ARTERY DISEASE, RECEIVING LONG-TERM MILDRONATE THERAPY
by: V. Ya. Dzerve, et al.
Published: (2011-02-01)

The effect of mildronate on the circadion biorhythm of the parametrs of the excretory renal function
by: R B Kosuba, et al.
Published: (2012-12-01)

TRIMETAZIDINE AND MILDRONATE AS DIRECT ACTION Β2 - ADRENOSENSIBILIZERS (EXPERIMENTAL EVIDENCE)
by: V. I. Tsirkin, et al.
Published: (2002-02-01)

CYTOPROTECTOR MILDRONATE IN CORRECTING MYOCARDIAL DYSFUNCTION AMONG STABLE ANGINA PATIENTS AFTER CORONARY REVASCULARISATION
by: I. G. Gordeev, et al.
Published: (2009-04-01)

Effectiveness of Mildronate®, combined with standard therapy, in the angina pectoris treatment
by: Dzerve Vilnis, et al.
Published: (2011-12-01)

THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: I. V. Sergienko, et al.
Published: (2015-12-01)

THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: I. V. Sergienko, et al.
Published: (2015-12-01)

New views of mildronate use for the prevention and correction of impairment of adaptive processes
by: L V Logunova
Published: (2009-03-01)

MILDRONATE THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE, TYPE 2 DIABETES MELLITUS AND AUTONOMOUS CARDIAC NEUROPATHY
by: M. E. Statsenko, et al.
Published: (2009-06-01)

Changes in fatty acids content in blood red cells of patients with iron-deficiency anemia treated with sorbifer and mildronate
by: E V Goncharova, et al.
Published: (2008-06-01)

Mildronate in complex chronic heart failure manD agement among patients in early postDinfarction period
by: M. E. Statsenko, et al.
Published: (2005-12-01)

CLINICAL EFFECTIVENESS OF MILDRONATE IN PATIENTS WITH CONNECTIVE TISSUE DYSPLASIA: EXPERIENCE OF THE SPECIALIZED CLINICAL CENTRE, OMSK CITY
by: G. I. Nechaeva, et al.
Published: (2011-06-01)

Influence of cardioprotectors mildronate and trimetazidine on MB-creatinkinase activity in stable angina patients after coronary bypass surgery
by: I. G. Gordeev, et al.
Published: (2004-12-01)

Endothelial dysfunction in heart failure with normal systolic function, and its correction with a metabolic agent, mildronate
by: V. P. Geychenko, et al.
Published: (2005-08-01)

MILDRONATE EFFECT ON ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH CHRONIC HEART FAILURE: DOUBLE BLIND CROSSOVER STUDY
by: L. G. Voronkov, et al.
Published: (2016-01-01)

EFFECTS OF MILDRONATE, AS A PART OF COMBINED HEART FAILURE THERAPY, ON CARBOHYDRATE AND LIPID METABOLISM AND OXIDATIVE STRESS PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2010-04-01)

Protection of Testis against Lipopolysaccharide-Induced Toxicity: Mildronate-Induced L-Carnitine Depletion as a Modulator of Gut Microbiome Composition and Gastrointestinal Inflammation
by: Artem P. Gureev, et al.
Published: (2023-12-01)

EFFECTIVENESS OF ROSUVASTATIN IN VERY HIGH RISK CARDIOVASCULAR PATIENTS IN THE ACTUAL OUTPATIENT PRACTICE
by: V. P. Mikhin, et al.
Published: (2015-12-01)

Efficacy of a fixed-dose combination (amlodipine/losartan) in the treatment of a patient with arterial hypertension, dyslipidemia and obesity
by: V. P. Mikhin
Published: (2020-01-01)

Content of matrix metalloproteinases in the blood of hypertensive patients with a high cardiovascular risk receiving statin therapy
by: V. P. Mikhin, et al.
Published: (2022-11-01)

PATIENTS WITH ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOSPITALIZATION STRUCTURE AND ANTITHROMBOTIC THERAPY (RECVASA AF-KURSK REGISTRY)
by: V. P. Mikhin, et al.
Published: (2017-05-01)

ANTI-ISCHEMIC AND ANTIOXIDANT ACTIVITY OF MELDONIUM IN IHD PATIENTS WITH STABLE ANGINA
by: V. P. MIKHIN, et al.
Published: (2016-12-01)

CYTOPROTECTOR ROLE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION TREATED WITH ENALAPRIL
by: F. E. Khebodarov, et al.
Published: (2009-10-01)

Antidepressant therapy in patients with cardiovascular diseases
by: V. E. Medvedev, et al.
Published: (2019-03-01)

The potential role of miRNAs in calcification of cardiovascular diseases
by: A. G. Ibragimova, et al.
Published: (2019-11-01)